Artykuły w czasopismach na temat „CD8+ Treg cells”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „CD8+ Treg cells”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Panda, Abir Kumar, and Ethan M. Shevach. "CD28 co-stimulation drives memory phenotype (MP) Treg cell and MP CD4+Foxp3− effector T cell homeostatic proliferation." Journal of Immunology 200, no. 1_Supplement (2018): 112.11. http://dx.doi.org/10.4049/jimmunol.200.supp.112.11.
Pełny tekst źródłaCeeraz, Sabrina, Charlotte R. Thompson, Richard Beatson, and Ernest H. Choy. "Harnessing CD8+CD28− Regulatory T Cells as a Tool to Treat Autoimmune Disease." Cells 10, no. 11 (2021): 2973. http://dx.doi.org/10.3390/cells10112973.
Pełny tekst źródłaGardell, Jennifer L., Courtney Crane, Justin Bowser, et al. "Bispecific CD8 Treg modulators regulate a novel regulatory CD8 T cell network and eliminate pathogenic CD4 T cells in live cell co-culture system." Journal of Immunology 208, no. 1_Supplement (2022): 174.16. http://dx.doi.org/10.4049/jimmunol.208.supp.174.16.
Pełny tekst źródłaZhang, Zhu Xu, Ye Su, Xuyan Huang, Dameng Lian, and Anthony Jevnikar. "CD4+ but not CD8+ memory T cells escape DN Tregs-mediated regulation via expression of Serpin Protease Inhibitor 6 (P2160)." Journal of Immunology 190, no. 1_Supplement (2013): 69.18. http://dx.doi.org/10.4049/jimmunol.190.supp.69.18.
Pełny tekst źródłaMaurer, Meghan, Justin Bowser, Rachael Fasnacht, et al. "Demonstration of regulatory CD8 T cell prevalence, phenotype, and functions in autoimmune patients treated with a tolerizing peptide vaccine." Journal of Immunology 208, no. 1_Supplement (2022): 123.10. http://dx.doi.org/10.4049/jimmunol.208.supp.123.10.
Pełny tekst źródłaRushbrook, Simon M., Scott M. Ward, Esther Unitt, et al. "Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Persistent Hepatitis C Virus Infection." Journal of Virology 79, no. 12 (2005): 7852–59. http://dx.doi.org/10.1128/jvi.79.12.7852-7859.2005.
Pełny tekst źródłaBotta, Gregory P., Tatiana Hurtado De Mendoza, Harri Jarvelainen, and Erkki Ruoslahti. "iRGD in combination with IL-2 reprograms tumor immunosuppression." Journal of Clinical Oncology 37, no. 8_suppl (2019): 55. http://dx.doi.org/10.1200/jco.2019.37.8_suppl.55.
Pełny tekst źródłaGardell, Jennifer, Daniel Boster, Justin Bowser, et al. "A NOVEL BISPECIFIC CD8 TREG MODULATOR TARGETING CYTOLYTIC CD8 REGULATORY T CELLS REDUCES PATHOGENIC CD4 T CELLS AND INFLAMMATION IN TRANSLATIONAL MODELS OF INTESTINAL AUTOIMMUNE AND INFLAMMATORY DISEASE." Inflammatory Bowel Diseases 29, Supplement_1 (2023): S12. http://dx.doi.org/10.1093/ibd/izac247.024.
Pełny tekst źródłaLi, Rong, Juan Xu, Ming Wu та ін. "Circulating CD4+ Treg, CD8+ Treg, and CD3+ γδ T Cell Subpopulations in Ovarian Cancer". Medicina 59, № 2 (2023): 205. http://dx.doi.org/10.3390/medicina59020205.
Pełny tekst źródłaYamagami, Wataru, Nobuyuki Susumu, Hideo Tanaka, et al. "Immunofluorescence-Detected Infiltration of CD4+FOXP3+ Regulatory T Cells is Relevant to the Prognosis of Patients With Endometrial Cancer." International Journal of Gynecologic Cancer 21, no. 9 (2011): 1628–34. http://dx.doi.org/10.1097/igc.0b013e31822c271f.
Pełny tekst źródłaYuan, Shiwen, Yanting Zeng, Jiawei Li, et al. "Phenotypical changes and clinical significance of CD4+/CD8+ T cells in SLE." Lupus Science & Medicine 9, no. 1 (2022): e000660. http://dx.doi.org/10.1136/lupus-2022-000660.
Pełny tekst źródłaPanda, Abir Kumar, and Ethan M. Shevach. "Inhibition of TCR-MHC-II interactions abrogates Treg-mediated immune suppression and augments anti-tumor immunity." Journal of Immunology 210, no. 1_Supplement (2023): 169.15. http://dx.doi.org/10.4049/jimmunol.210.supp.169.15.
Pełny tekst źródłaHouston, Timothy W., Quentin Howlett-Prieto, Colin Regenauer, et al. "Increased Percentage of CD8+CD28−Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis." Neurology - Neuroimmunology Neuroinflammation 10, no. 2 (2022): e200075. http://dx.doi.org/10.1212/nxi.0000000000200075.
Pełny tekst źródłaMansoori, Mohammad Nizam, Olena Kamenyeva, Juraj Kabat, and Ethan M. Shevach. "Tregs suppress antigen-specific CD8+ T cells in vivo by depleting pMHC-I complexes from Dendritic Cells." Journal of Immunology 208, no. 1_Supplement (2022): 54.10. http://dx.doi.org/10.4049/jimmunol.208.supp.54.10.
Pełny tekst źródłaGupta, Sudhir, Houfen Su, and Sudhanshu Agrawal. "CD8 Treg Cells Inhibit B-Cell Proliferation and Immunoglobulin Production." International Archives of Allergy and Immunology 181, no. 12 (2020): 947–55. http://dx.doi.org/10.1159/000509607.
Pełny tekst źródłaMurase, Kazuyuki, Yutaka Kawano, Jeremy Ryan, et al. "Differential Effects of TCR Stimulation and IL-2 On Apoptotic Pathways in CD4 Regulatory T Cells Compared to Conventional CD4 T Cells and CD8 T Cells." Blood 120, no. 21 (2012): 3280. http://dx.doi.org/10.1182/blood.v120.21.3280.3280.
Pełny tekst źródłaHolderried, Tobias A. W., Hye-Jung Kim, Philipp A. Lang, and Harvey Cantor. "CD8+ Treg - From Mouse To Man." Blood 122, no. 21 (2013): 3474. http://dx.doi.org/10.1182/blood.v122.21.3474.3474.
Pełny tekst źródłaSun, Juan, Yiming Yang, Xiaona Huo, et al. "Efficient Therapeutic Function and Mechanisms of Human Polyclonal CD8+CD103+Foxp3+ Regulatory T Cells on Collagen-Induced Arthritis in Mice." Journal of Immunology Research 2019 (February 19, 2019): 1–12. http://dx.doi.org/10.1155/2019/8575407.
Pełny tekst źródłaRagab, Ahmed A. Y., Margaret Doyle, Jiachen Chen, Yuan Fang, Kathryn Lunetta, and Joanne Murabito. "AGING-RELATED IMMUNE CELLS PHENOTYPES AND ALL-CAUSE MORTALITY IN THE FRAMINGHAM HEART STUDY." Innovation in Aging 7, Supplement_1 (2023): 862. http://dx.doi.org/10.1093/geroni/igad104.2776.
Pełny tekst źródłaFan, Huahua, Xiaona Huo, Juan Sun, Yiming Yang, and Xiao Li. "Efficient Induction and Expansion Of CD8+CD28+Foxp3+ Regulatory T Cells By TGF-beta1 and Rapamycin." Blood 122, no. 21 (2013): 190. http://dx.doi.org/10.1182/blood.v122.21.190.190.
Pełny tekst źródłaLiu, Chao, Yi Sun, Jinbo Yue, and Jinming Yu. "Prognostic interaction of smoking history with circulating regulatory T cells in advanced non-small cell lung cancer." Journal of Clinical Oncology 37, no. 15_suppl (2019): e14030-e14030. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14030.
Pełny tekst źródłaMansoori, Mohammad Nizam, Olena Kamenyeva, Juraj Kabat, and Ethan M. Shevach. "Regulatory T cells suppress antigen-specific CD8+ T cells in vivo by modulating the immune-synapse." Journal of Immunology 206, no. 1_Supplement (2021): 96.05. http://dx.doi.org/10.4049/jimmunol.206.supp.96.05.
Pełny tekst źródłaSrinivasan, Saranya, Ma Chaoyu, Shruti Mishra, Liwen Wang, Kenneth Fan, and Nu Zhang. "Age-dependent changes in the regulatory program of CD8+ Regulatory T cells (CD8+ Tregs)." Journal of Immunology 208, no. 1_Supplement (2022): 167.03. http://dx.doi.org/10.4049/jimmunol.208.supp.167.03.
Pełny tekst źródłaPreston, Claudia, Matthew Maurer, Ann Oberg, et al. "CD4+CD25+FOXP3+ regulatory T cells and association with survival in epithelial ovarian cancer (74.9)." Journal of Immunology 188, no. 1_Supplement (2012): 74.9. http://dx.doi.org/10.4049/jimmunol.188.supp.74.9.
Pełny tekst źródłaZhang, Hong, Anil Pahuja, Kelly Lundsten, et al. "Sustained Treg expansion by repeated in vivo injection of anti-TNFRSF25 mAb (P4142)." Journal of Immunology 190, no. 1_Supplement (2013): 191.17. http://dx.doi.org/10.4049/jimmunol.190.supp.191.17.
Pełny tekst źródłaHan, Jing Light, Jason Zimmerer, Qiang Zeng, Sachi Chaudhari, Christopher Breuer, and Ginny L. Bumgardner. "Deficiency of antibody-suppressor CXCR5+CD8+ T cells (not CD4+ Tregs) drives high alloantibody production in CCR5 KO kidney transplant recipients." Journal of Immunology 208, no. 1_Supplement (2022): 175.09. http://dx.doi.org/10.4049/jimmunol.208.supp.175.09.
Pełny tekst źródłaSchuler, Patrick, William Buchanan, Sharon Riddler, Theresa Whiteside, Macatangay Bernard, and Charles Rinaldo. "Reverse correlation between CD39+CD25+ Treg and activated CD8+ T cells / NK cells in HIV-1- patients with low CD4 cell counts (105.48)." Journal of Immunology 186, no. 1_Supplement (2011): 105.48. http://dx.doi.org/10.4049/jimmunol.186.supp.105.48.
Pełny tekst źródłaHolderried, Tobias A. W., Pia Sauerborn, Hye-Jung Kim, Harvey Cantor, Dominik Wolf, and Peter Brossart. "Human CD8+ Treg after Allogeneic Stem-Cell Transplantation." Blood 128, no. 22 (2016): 2243. http://dx.doi.org/10.1182/blood.v128.22.2243.2243.
Pełny tekst źródłaCrane, Courtney, Justin Bowser, Rachael Fasnacht, et al. "A NEWLY DISCOVERED REGULATORY CD8 T CELL NETWORK HAS THE POTENTIAL TO REGULATE AND ELIMINATE PATHOGENIC CD4 T CELLS IN AUTOIMMUNE MEDIATED DISEASE OF THE GUT." Inflammatory Bowel Diseases 28, Supplement_1 (2022): S55. http://dx.doi.org/10.1093/ibd/izac015.086.
Pełny tekst źródłaDeyev, Vadim, Melinda Roskos, Robert B. Levy, and Eckhard R. Podack. "TNFR25 Expression on CD4+CD25+ T Cells: Down Modulation of Regulatory Activity." Blood 108, no. 11 (2006): 3165. http://dx.doi.org/10.1182/blood.v108.11.3165.3165.
Pełny tekst źródłaUrbieta, Maite, Isabel Barao, Monica Jones, William J. Murphy, and Robert B. Levy. "Regulation of Hematopoietic Colony Forming Cells by CD4+CD25+ T Cells: A Role for T Regulatory Cells in Hematopoiesis?." Blood 108, no. 11 (2006): 3181. http://dx.doi.org/10.1182/blood.v108.11.3181.3181.
Pełny tekst źródłaGonzalez-Rey, Elena, Alejo Chorny, Amelia Fernandez-Martin, Doina Ganea, and Mario Delgado. "Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells." Blood 107, no. 9 (2006): 3632–38. http://dx.doi.org/10.1182/blood-2005-11-4497.
Pełny tekst źródłaHall, Bruce Milne, Nirupama Darshan Verma, Catherine Margaret Robinson, et al. "Recently alloactivated CD4+CD8−CD25+T regulatory cells express CD8alpha and are potent suppressor cells." Journal of Immunology 202, no. 1_Supplement (2019): 57.20. http://dx.doi.org/10.4049/jimmunol.202.supp.57.20.
Pełny tekst źródłaTran, Dat, Ossama Maher, Charlotte Rivas та Shannon Moree. "Reduced and skewed TCR Vβ repertoire in CD8 compared to Foxp3+ regulatory T cells in acute gastrointestinal graft versus host disease (TRAN1P.947)". Journal of Immunology 194, № 1_Supplement (2015): 140.29. http://dx.doi.org/10.4049/jimmunol.194.supp.140.29.
Pełny tekst źródłaLiu, Hsin-Yu, Christophe Pedros, Ann Balancio, Kok-Fai Kong, and Amnon Altman. "Protein kinase C-eta is required for Treg-mediated suppression of anti-tumor and viral immunity." Journal of Immunology 204, no. 1_Supplement (2020): 244.14. http://dx.doi.org/10.4049/jimmunol.204.supp.244.14.
Pełny tekst źródłaBeres, Amy, Dipica Haribhai, Chelsea Tessler-Verville, et al. "Induction of a Novel Population of CD8+ Foxp3+ Regulatory T Cells During Graft Versus Host Disease." Blood 118, no. 21 (2011): 821. http://dx.doi.org/10.1182/blood.v118.21.821.821.
Pełny tekst źródłaYang, Zhi-Zhang, Anne J. Novak, Mary J. Stenson, Thomas E. Witzig, and Stephen M. Ansell. "Intratumoral Treg Cells Completely Inhibit the Induction and Function of Tumor-Infiltrating CD8+ T-Cells in B-Cell NHL." Blood 106, no. 11 (2005): 3311. http://dx.doi.org/10.1182/blood.v106.11.3311.3311.
Pełny tekst źródłaGardell, Jennifer L., Daniel Boster, Justin Bowser, et al. "A KIR x CD8 targeting bispecific modulator enhances regulatory CD8 T cell functions, and reduces inflammation in models of autoimmune disease." Journal of Immunology 210, no. 1_Supplement (2023): 85.17. http://dx.doi.org/10.4049/jimmunol.210.supp.85.17.
Pełny tekst źródłaMansoori, Mohammad Nizam, and Ethan Menahem Shevach. "Regulatory T cells suppression of antigen-specific CD8+ T cells in vivo is contact-dependent." Journal of Immunology 204, no. 1_Supplement (2020): 72.1. http://dx.doi.org/10.4049/jimmunol.204.supp.72.1.
Pełny tekst źródłaWasnik, Samiksha, David J. Baylink, Jianmei Leavenworth, Chenfan Liu, Hongzheng Bi, and Xiaolei Tang. "Towards Clinical Translation of CD8+ Regulatory T Cells Restricted by Non-Classical Major Histocompatibility Complex Ib Molecules." International Journal of Molecular Sciences 20, no. 19 (2019): 4829. http://dx.doi.org/10.3390/ijms20194829.
Pełny tekst źródłaAliazis, Konstantinos, Anthos Christofides, Halil-Ibrahim Aksoylar, et al. "Specific PD-1 Deletion on Regulatory T Cells Leads to Enhanced Anti-Tumor Responses." Blood 142, Supplement 1 (2023): 2551. http://dx.doi.org/10.1182/blood-2023-174422.
Pełny tekst źródłaIwamoto, Miki, Ken-ichi Matsuoka, Yusuke Meguri, et al. "Very Early Dynamics of Regulatory T-Cell Chimerism Significantly Varies According to the Donor Sources: Implication for Basic Immune Pathogenesis of Engraftment Phase." Blood 128, no. 22 (2016): 4575. http://dx.doi.org/10.1182/blood.v128.22.4575.4575.
Pełny tekst źródłaKim, Yong-Hee, Abir K. Panda, and Ethan M. Shevach. "Treg cell depletion in adult mice results in activation of antigen-presenting cells prior to fatal autoimmune disease." Journal of Immunology 210, no. 1_Supplement (2023): 248.03. http://dx.doi.org/10.4049/jimmunol.210.supp.248.03.
Pełny tekst źródłaManuszak, Claire, Martha Brainard, Emily Thrash, F. Stephen Hodi, and Mariano Severgnini. "Standardized 11-color flow cytometry panel for the functional phenotyping of human T regulatory cells." Journal of Biological Methods 7, no. 2 (2020): e131. http://dx.doi.org/10.14440/jbm.2020.325.
Pełny tekst źródłaLui, Jenbon, Priya Devarajan, Sarah Teplicki, Jason Miska, and Zhibin Chen. "Gut-associated cross-differentiation of T lymphocyte lineages (LYM7P.726)." Journal of Immunology 192, no. 1_Supplement (2014): 193.14. http://dx.doi.org/10.4049/jimmunol.192.supp.193.14.
Pełny tekst źródłaDrerup, Justin Michael, Alvaro Souto Padron, Wanjiao Chen, Curtis Anthony Clark, and Tyler Jay Curiel. "Manipulation of IL-2 signals by IL-2/antibody complex and CD25 blockade improves tumor immunity, reprograms regulatory T cells, and augments CD8+ central memory in an ovarian cancer model." Journal of Immunology 196, no. 1_Supplement (2016): 212.22. http://dx.doi.org/10.4049/jimmunol.196.supp.212.22.
Pełny tekst źródłaFoureau, David, Iain McKillop, Chase Jones, Asim Amin, Richard White, and Jonathan Salo. "Skin Tumor Responsiveness to IL-2 Treatment Correlates to CD8 Treg Expansion in an Immunocompetent Mouse Model. (100.15)." Journal of Immunology 184, no. 1_Supplement (2010): 100.15. http://dx.doi.org/10.4049/jimmunol.184.supp.100.15.
Pełny tekst źródłaFullerton, Benjamin, Robyn Gartrell, Thomas Enzler, et al. "872 Neoadjuvant chemoradiotherapy enhances T cell infiltration in pancreatic ductal adenocarcinoma but high percentage of regulatory T cells associates with poor survival." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (2020): A924—A925. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0872.
Pełny tekst źródłaKim, Jung-Sik, Kyeo-Rae Han, and Chung-Gyu Park. "Novel Consistently Ex-vivo Expanded CD8+CD25+FoxP3+Treg Cells Prolongs the Allogeneic Islet Survival." Journal of Immunology 200, no. 1_Supplement (2018): 55.39. http://dx.doi.org/10.4049/jimmunol.200.supp.55.39.
Pełny tekst źródłaZhu, Qin, Jiaqi Yuan, Yuqiong He, and Yu Hu. "The Effect of miR-520b on Macrophage Polarization and T Cell Immunity by Targeting PTEN in Breast Cancer." Journal of Oncology 2021 (October 6, 2021): 1–19. http://dx.doi.org/10.1155/2021/5170496.
Pełny tekst źródła